AVTR — Avantor, Inc.

NYSE · Unknown · Unknown · CIK 1722482 ·
Last close
$9.43
Market Cap
$6.44B
52W High
$10.06
52W Low
$7.26
ADV30
9,777,980
Next earnings
2026-04-29
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 1,581,400,000 500,700,000 99,500,000 43,300,000 11,663,000,000 279,300,000 6,074,300,000
Dec 2025 1,663,600,000 523,900,000 131,500,000 52,400,000 11,794,700,000 365,400,000 6,229,700,000
Sep 2025 1,623,800,000 526,500,000 136,200,000 -711,800,000 11,675,900,000 251,900,000 6,105,700,000
Jun 2025 1,683,400,000 554,100,000 128,800,000 64,700,000 12,776,900,000 449,400,000 6,491,000,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$573,200,000
Investing CF
$-134,300,000
Financing CF
$-483,000,000
CapEx
$-134,300,000
Dividends Paid
Buybacks
$-79,400,000
EPS Diluted TTM
$-0.81
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$1,716,100,000
Inventory
$810,300,000
Receivables
$1,104,800,000
ST Investments
EBIT TTM
$-301,000,000
Pretax Income TTM
$-471,500,000
Interest Exp TTM
$170,500,000
Analysts
13

Yahoo Snapshot (yfinance, live)

Total Revenue
$6,552,200,192
EBITDA
$948,099,968
Free Cash Flow
$489,362,496
Enterprise Value
$9,975,383,040
Total Cash
$279,300,000
Total Debt
$3,816,300,032
Shares Out
682,755,402
Trailing EPS
$-0.81
Book Value
$8.26
ROE
-9.4%
ROA
2.8%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 6,552,200,000 543,900,000 -530,200,000 11,794,700,000 6,229,700,000 623,800,000
Dec 2024 6,783,600,000 638,200,000 711,500,000 12,114,500,000 6,157,800,000 840,800,000
Dec 2023 6,967,200,000 857,200,000 321,100,000 12,972,700,000 7,720,100,000 870,000,000
Dec 2022 7,512,400,000 1,130,200,000 686,500,000 13,464,300,000 8,608,900,000 843,600,000

TTM Snapshot

Revenues TTM
$7,113,800,000
NetIncome TTM
$525,100,000
OpCashFlow TTM
$0
Assets (Latest)
$12,114,500,000
Forward EPS
$0.85

News headlines (Yahoo Finance, 1h cache)

[Latest] Global Density Gradient Media Market Size/Share Worth USD 5.3 Billion by 2035 at a 11.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growt
2026-06-24 16:30 · Yahoo
Q1 Rundown: Avantor (NYSE:AVTR) Vs Other Research Tools & Consumables Stocks
2026-06-19 18:36 · Yahoo
Avantor (AVTR) Gets Underperform Rating From Wolfe Research
2026-06-17 09:59 · Yahoo
1 Healthcare Stock for Long-Term Investors and 2 We Turn Down
2026-06-16 14:09 · Yahoo
CVS Health (CVS) Up 8.5% Since Last Earnings Report: Can It Continue?
2026-06-05 15:30 · Yahoo
Why Is Revvity (RVTY) Up 2% Since Last Earnings Report?
2026-06-04 15:30 · Yahoo
Is Avantor (AVTR) Elevating Quality To A Strategic Edge With Its New Regulatory Chief?
2026-06-01 14:07 · Yahoo
Avantor (AVTR) Appoints Ludovic Brellier as EVP and Chief Transformation Officer
2026-06-01 11:37 · Yahoo
Why Is Avantor (AVTR) Up 13% Since Last Earnings Report?
2026-05-29 15:30 · Yahoo
Here's Why You Should Hold Avantor Stock in Your Portfolio for Now
2026-05-29 15:10 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.